Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

Journal of Neurochemistry

Volumn 141, Issue 2, 2017, Pages 195-207

  Pawlosky, Robert J ^a   Kemper, Martin F ^a   Kashiwaya, Yoshihero ^a   King, Michael Todd ^a   Mattson, Mark P ^b   Veech, Richard L ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cellular energetics; glycolysis; hippocampus; ketone bodies; mitochondria

Indexed keywords

1,3 BUTANEDIOL; 3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; AMINO ACID; ASPARTIC ACID; ESTER DERIVATIVE; GLUCOSE; GLUTAMIC ACID; KETONE ESTER; LIPID; N ACETYLASPARTIC ACID; PERCHLORIC ACID; UNCLASSIFIED DRUG; BUTANE; HYDROXYBUTYRIC ACID; KETONE BODY;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CITRIC ACID CYCLE; CONTROLLED STUDY; DIET; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOLYSIS; HIPPOCAMPUS; HYDROLYSIS; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; DIET THERAPY; DISEASE MODEL; KETOGENIC DIET; METABOLISM; PHYSIOLOGY; PROCEDURES;

ALZHEIMER DISEASE; AMINO ACIDS; ANIMALS; BUTANES; CITRIC ACID CYCLE; DISEASE MODELS, ANIMAL; GLYCOLYSIS; HIPPOCAMPUS; HYDROXYBUTYRATES; KETOGENIC DIET; KETONE BODIES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 85015368086     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13958     Document Type: Article

References (43)

1. Andrews M. T., Russeth K. P., Drewes L. R. and Henry P. G. (2009) Adaptive mechanisms regulate preferred utilization of ketones in the heart and brain of a hibernating mammal during arousal from torpor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R383–R393.
2. Beckett T. L., Studzinski C. M., Keller J. N., Paul Murphy M. and Niedowicz D. M. (2013) A ketogenic diet improves motor performance but does not affect beta-amyloid levels in a mouse model of Alzheimer's disease. Brain Res. 1505, 61–67.
3. 2+ on ATP linked enzymes and the calculation of Gibbs free energy of ATP hydrolysis. J. Phys. Chem. B 114, 16137–16146.
4. Bretillon L., Siden A., Wahlund L. O. et al. (2000) Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci. Lett. 293, 87–90.
5. Brownlow M. L., Benner L., D'Agostino D., Gordon M. N. and Morgan D. (2013) Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology. PLoS ONE 8, e75713.
6. Burlot M. A., Braudeau J., Michaelsen-Preusse K. et al. (2015) Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Hum. Mol. Genet. 24, 5965–5976.
7. Chance B., Sies H. and Boveris A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527–605.
8. Clarke K., Tchabanenko K., Pawlosky R. et al. (2012) Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 63, 401–408.
9. Cunnane S., Nugent S., Roy M. et al. (2011) Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 27, 3–20.
10. Ding F., Yao J., Rettberg J. R., Chen S. and Brinton R. D. (2013a) Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. PLoS ONE 8, e79977.
11. Ding F., Yao J., Zhao L., Mao Z., Chen S. and Brinton R. D. (2013b) Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. PLoS ONE 8, e59825.
12. Frackowiak R. S., Pozzilli C., Legg N. J., Du Boulay G. H., Marshall J., Lenzi G. L. and Jones T. (1981) Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 104, 753–778.
13. Ghosh D., LeVault K. R., Barnett A. J. and Brewer G. J. (2012) A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons. J. Neurosci. 32, 5821–5832.
14. Ghosh D., Levault K. R. and Brewer G. J. (2014) Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons. Aging Cell 13, 631–640.
15. Guynn R. W., Gelberg H. J. and Veech R. L. (1973) Equilibrium constants of the malate dehydrogenase, citrate synthase, citrate lyase, and acetyl coenzyme A hydrolysis reactions under physiological conditions. J. Biol. Chem. 248, 6957–6965.
16. Jo S., Yarishkin O., Hwang Y. J. et al. (2014) GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat. Med. 20, 886–896.
17. Kapogiannis D. and Mattson M. P. (2011) Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 10, 187–198.
18. Kashiwaya Y., Pawlosky R., Markis W., King M. T., Bergman C., Srivastava S., Murray A., Clarke K. and Veech R. L. (2010) A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat. J. Biol. Chem. 285, 25950–25956.
19. Kashiwaya Y., Bergman C., Lee J. H. et al. (2013) A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol. Aging 34, 1530–1539.
20. Kemper M. F., Zhao Y. Z., Duckles S. P. and Krause D. N. (2013) Endogenous ovarian hormones affect mitochondrial efficiency in cerebral endothelium via distinct regulation of PGC-1 isoforms. J. Cereb. Blood Flow Metab. 33, 122–128.
21. Kemper M. F., Srivastava S., Todd King M., Clarke K., Veech R. L. and Pawlosky R. J. (2015) An ester of beta-hydroxybutyrate regulates cholesterol biosynthesis in rats and a cholesterol biomarker in humans. Lipids 50, 1185–1193.
22. Krikorian R., Shidler M. D., Dangelo K., Couch S. C., Benoit S. C. and Clegg D. J. (2012) Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol. Aging 33, 425.e419–425.e427.
23. Kwak Y. D., Wang R., Li J. J., Zhang Y. W., Xu H. and Liao F. F. (2011) Differential regulation of BACE1 expression by oxidative and nitrosative signals. Mol. Neurodegener. 6, 17.
24. de Leon M. J., Ferris S. H., George A. E. et al. (1983) Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am. J. Neuroradiol. 4, 568–571.
25. Londesborough J. C. and Dalziel K. (1968) The equilibrium constant of the isocitrate dehydrogenase reaction. Biochem. J. 110, 217–222.
26. Mathew S. J., Price R. B., Mao X., Smith E. L. P., Coplan J. D., Charney D. S. and Shungu D. C. (2008) Hippocampal n-acetylaspartate concentration and response to Riluzole in generalized anxiety disorder. Biol. Psychiatry 63, 891–898.
27. Mattson M. P. (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631–639.
28. Meidenbauer J. J., Mukherjee P. and Seyfried T. N. (2015) The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer. Nutr. Metab. 12, 12.
29. Mosconi L., Pupi A. and De Leon M. J. (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann. N. Y. Acad. Sci. 1147, 180–195.
30. Murray A. J., Knight N. S., Cole M. A. et al. (2016) Novel ketone diet enhances physical and cognitive performance. FASEB J. 12, 4021–4032.
31. Newport M. T., VanItallie T. B., Kashiwaya Y., King M. T. and Veech R. L. (2015) A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease. Alzheimers Dement. 11, 99–103.
32. Pawlosky R. J., Kashiwaya Y., Srivastava S., King M. T., Crutchfield C., Volkow N., Kunos G., Li T. K. and Veech R. L. (2010) Alterations in brain glucose utilization accompanying elevations in blood ethanol and acetate concentrations in the rat. Alcohol. Clin. Exp. Res. 34, 375–381.
33. Prins M. L. (2008) Cerebral metabolic adaptation and ketone metabolism after brain injury. J. Cereb. Blood Flow Metab. 28, 1–16.
34. Sato K., Kashiwaya Y., Keon C. A., Tsuchiya N., King M. T., Radda G. K., Chance B., Clarke K. and Veech R. L. (1995) Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9, 651–658.
35. Srivastava S., Kashiwaya Y., Chen X., Geiger J. D., Pawlosky R. and Veech R. L. (2012a) Microwave irradiation decreases ATP, increases free [Mg(2)(+)], and alters in vivo intracellular reactions in rat brain. J. Neurochem. 123, 668–675.
36. Srivastava S., Kashiwaya Y., King M. T., Baxa U., Tam J., Niu G., Chen X., Clarke K. and Veech R. L. (2012b) Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet. FASEB J. 26, 2351–2362.
37. Veech R. L. (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids 70, 309–319.
38. Veech R. L. and King M. T. (2016) Alzheimer's Disease Causes and Treatment, in Ketogenic Diet and Metabolic therapies (Masino S., ed.), pp. 241–253. Oxford University Press, USA.
39. Veech R. L., Eggleston L. V. and Krebs H. A. (1969) The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem. J. 115, 609–619.
40. Veech R. L., Chance B., Kashiwaya Y., Lardy H. A. and Cahill G. F., Jr (2001) Ketone bodies, potential therapeutic uses. IUBMB Life 51, 241–247.
41. Williamson D. H., Lund P. and Krebs H. A. (1967) The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 103, 514–527.
42. Yao J., Irwin R. W., Zhao L., Nilsen J., Hamilton R. T. and Brinton R. D. (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 106, 14670–14675.
43. Yao J., Chen S., Mao Z., Cadenas E. and Brinton R. D. (2011) 2-Deoxy-d-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS ONE 6, e21788.